# Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

> **NCT03006809** · PHASE1 · COMPLETED · sponsor: **Najwa Elnachef** · enrollment: 30 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation (FMT), OpenBiome
- **OTHER:** pretreatment antibiotics

## Key facts

- **NCT ID:** NCT03006809
- **Lead sponsor:** Najwa Elnachef
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2020-05-04
- **Final completion:** 2021-04-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006809, "Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03006809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*